NCT01692873
Completed
Not Applicable
Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004
Institut Paoli-Calmettes2 sites in 1 country274 target enrollmentFebruary 1, 2012
ConditionsPancreatic Tumor
Interventionssuspected pancreatic tumor
Overview
- Phase
- Not Applicable
- Intervention
- suspected pancreatic tumor
- Conditions
- Pancreatic Tumor
- Sponsor
- Institut Paoli-Calmettes
- Enrollment
- 274
- Locations
- 2
- Primary Endpoint
- Biomarkers
- Status
- Completed
- Last Updated
- 11 days ago
Overview
Brief Summary
Pancreatic cancer is among the most serious human neoplasia and the most difficult to treat.
Most patients present at diagnosis a non resectable, locally advanced or metastatic disease, with a median survival of 12 month.
The aim of this study is the identification of diagnosis biomarkers, predictive of the therapeutic response.
This project investigate the use of molecular analyses applied to pancreatic tumor cells collected by microbiopsy under ultrasound-endoscopy, and blood cells.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Suspicion of pancreatic adenocarcinoma
- •Patient \> 18 years old
- •Social Security affiliation
- •Signed informed consent
Exclusion Criteria
- •Patient in emergency situation
- •Major person being the object of a legal protective measure or unable to express its consent
Arms & Interventions
suspected pancreatic tumor
Realization of pancreatic tumor biopsy and blood samples
Intervention: suspected pancreatic tumor
Outcomes
Primary Outcomes
Biomarkers
Time Frame: within twenty four hours
Genomics, transcriptomics and proteomics analyses to determine presence or absence of biomarkers
Secondary Outcomes
- Histology(within twenty four hours)
Study Sites (2)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive MethodologyPancreatic NeoplasmsNCT04370574University Hospital, Montpellier200
Recruiting
Not Applicable
BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")Pancreatic CancerNCT03311776Inna Chen, MD5,000
Unknown
Not Applicable
Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic CancerPancreatic CancerNCT01127815National Taiwan University Hospital300
Active, not recruiting
Not Applicable
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid BiopsyPancreas AdenocarcinomaNCT04241367National Cancer Center, Korea420
Unknown
Not Applicable
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics TechniquesPatientsNCT05088161The Affiliated Hospital of Qingdao University20